Lexeo Therapeutics (LXEO) Cash from Operations (2022 - 2023)
Historic Cash from Operations for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to -$14.0 million.
- Lexeo Therapeutics' Cash from Operations rose 1590.88% to -$14.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$59.5 million, marking a year-over-year change of. This contributed to the annual value of -$81.2 million for FY2024, which is 3639.74% down from last year.
- According to the latest figures from Q4 2023, Lexeo Therapeutics' Cash from Operations is -$14.0 million, which was up 1590.88% from -$13.9 million recorded in Q3 2023.
- Lexeo Therapeutics' Cash from Operations' 5-year high stood at -$13.2 million during Q2 2023, with a 5-year trough of -$18.4 million in Q1 2023.